INTRODUCTION: Thromboelastography (TEG) was performed to assess potential @entity49 in @entity1985 ( @entity1985 ) @entity1 with @entity8 ( @entity8 ) and to explore correlated factors contributing to @entity49 status MATERIALS AND METHODS: 101 @entity8 @entity1 , 61 @entity1987 ( @entity1987 ) @entity1 and 20 healthy controls met the inclusion criteria. The @entity8 and @entity1987 @entity1 were stratified into two layers according to @entity8667 ( @entity8667 ) levels (<20g/l or 20-30g/l). Primary outcome measures included reaction time (R), a-angle, maximum amplitude (MA) and coagulation index (CI). TEG parameters of four @entity1 subgroups were analyzed in factorial designed ANOVA with factors disease and @entity8667 . RESULTS: By linear regression analysis, TEG parameters in @entity8 @entity1 correlated with @entity8667 (P<0.01) and the ANOVA for factorial designed data confirmed that the main effects of factors @entity8667 and disease were both statistically significant. Besides, comparison between control group and @entity1 subgroups showed that R value in normal controls was significantly higher than that in @entity8 subgroups, but was not statistically different from that in @entity1987 subgroups. @entity1985 @entity1 ( @entity1987 , @entity8 ) had significantly highera-angle, MA and CI values than healthy controls (p<0.05). CONCLUSIONS: @entity8 @entity1 tend to be more @entity49 than normal and @entity1987 @entity1 . @entity49 in @entity8 @entity1 involves the whole thrombotic processes acceleration (activated intrinsic pathway, fibrinogen, platelet function and fibrin-platelet interaction), whereas @entity49 state in @entity1987 @entity1 may be that the coagulation factors are not fully activated. Greater efforts should be made to prevent @entity49 especially for @entity8 @entity1 with severe @entity4988 .

Mechanisms of XXXX in @entity1985 associated with @entity8 as assessed by thromboelastography.

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity8 :: ('MESH:D007674', 'Disease') :: ['membranous nephropathy', 'MN'] @entity1987 :: ('MESH:D009402', 'Disease') :: ['MCD', 'minimal change disease'] @entity4988 :: ('MESH:D034141', 'Disease') :: ['hypoalbuminemia'] @entity49 :: ('MESH:D019851', 'Disease') :: ['hypercoagulable', 'Hypercoagulability', 'hypercoagulability'] @entity8667 :: ('MESH:D012713', 'Disease') :: ['SALB', 'serum albumin'] @entity1985 :: ('MESH:D009404', 'Disease') :: ['NS', 'Nephrotic syndrome']
@entity49 :: (MESH:D019851,Disease) :: ['hypercoagulability']
